Literature DB >> 11714229

Bagremycin A and B, novel antibiotics from streptomyces sp. Tü 4128.

M Bertasso1, M Holzenkämpfer, A Zeeck, F Dall'Antonia, H P Fiedler.   

Abstract

Two novel secondary metabolites, bagremycin A (2) and B (3), were detected in the culture filtrate of Streptomyces sp. Tü 4128 by HPLC-diode-array screening. They are phenol esters of 3-amino-4-hydroxybenzoic acid with a derivative of p-coumaric acid and show a moderate activity against gram-positive bacteria and some fungi.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11714229     DOI： 10.7164/antibiotics.54.730

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  3 in total

1.  On the Risks of Phylogeny-Based Strain Prioritization for Drug Discovery: Streptomyces lunaelactis as a Case Study.

Authors:  Loïc Martinet; Aymeric Naômé; Dominique Baiwir; Edwin De Pauw; Gabriel Mazzucchelli; Sébastien Rigali
Journal:  Biomolecules       Date:  2020-07-10

2.  New Antibacterial Bagremycins F and G from the Marine-Derived Streptomyces sp. ZZ745.

Authors:  Di Zhang; Chenyan Shu; Xiaoyuan Lian; Zhizhen Zhang
Journal:  Mar Drugs       Date:  2018-09-12       Impact factor: 5.118

3.  A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.

Authors:  Loïc Martinet; Aymeric Naômé; Benoit Deflandre; Marta Maciejewska; Déborah Tellatin; Elodie Tenconi; Nicolas Smargiasso; Edwin de Pauw; Gilles P van Wezel; Sébastien Rigali
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.